In Control Nicotine Lozenge and Moxetumomab Pasudotox-tdfk
Determining the interaction of In Control Nicotine Lozenge and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: nicotine
Brand name: Leader Nicotine Polacrilex, Nicorelief, Nicorette, Thrive, Commit, Habitrol, Nicoderm C-Q, Nicotine System Kit, Nicoderm CQ, Nicotrol Inhaler, Nicotrol NS
Synonyms: Nicotine Gum and Lozenges, Nicotine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- In Control Nicotine Lozenge-Moxetumomab pasudotox-tdfk Intravenous
- In Control Nicotine Lozenge-Moxifloxacin
- In Control Nicotine Lozenge-Moxifloxacin (Systemic)
- In Control Nicotine Lozenge-Moxifloxacin Hydrochloride
- In Control Nicotine Lozenge-Moxifloxacin Injection
- In Control Nicotine Lozenge-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-In-111 DTPA
- Moxetumomab Pasudotox-tdfk-Inamrinone
- Moxetumomab Pasudotox-tdfk-Inapsine
- Moxetumomab Pasudotox-tdfk-Inatal Advance
- Moxetumomab Pasudotox-tdfk-Inatal Ultra
- Moxetumomab Pasudotox-tdfk-Inbrija